Sterling Johnson joins Ethics Talk to discuss his article, coauthored with Dr Kimberly L. Sue: "Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.”
Dr Oluwole Jegede joins Ethics Talk to discuss his article, coauthored with Drs Julio C. Nunes, Terence Tumenta, Carmen Black, and Joao P. DeAquino: “What Would Equitable Harm Reduction Look Like?”
Dr Elizabeth Salisbury-Afshar joins Ethics Talk to discuss her article, coauthored with Drs Catherine J. Livingston and Ricky N. Bluthenthal: “How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder?”
Dr Ellen L. Edens joins Ethics Talk to discuss her article, coauthored with Drs Gabriela Garcia Vassallo and Robert Heimer: "How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice?”
Physicians should use evidence-based guidelines as a starting point to make sound clinical treatment decisions for a patient's individual medical needs.
Physicians should use evidence-based guidelines as a starting point to make sound clinical treatment decisions for a patient's individual medical needs.
Physicians should use evidence-based guidelines as a starting point to make sound clinical treatment decisions for a patient's individual medical needs.
Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.
A Canadian physician reports there is systematic bias to the outcome of published research funded by the pharmaceutical industry and believes more steps need to be taken to improve the integrity of clinical research reports in the United States and Canada.